Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GENE | VRPX | ZVSA | ||
| Company | Genetic Tech Spn ADR | Virpax Pharmaceuticals Inc | Zyversa Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.8000 | 1.5500 | 3.91 | ||
| High | 0.8400 | 1.6797 | 4.05 | ||
| Low | 0.7700 | 1.4200 | 3.75 | ||
| Last | 0.7760 | 1.5900 | 3.86 | ||
| Change | -0.0302 | -0.1100 | -0.05 | ||
| % Change | -3.75% | -6.47% | -1.28% | ||
| Volume | 28,900 | 2,420,900 | 54,500 | ||
| 20-Day Average Volume | 92,590 | 17,997,186 | 269,760 | ||
| Previous Close | 0.8062 | 1.7000 | 3.91 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.2057 | 1.0137 | 4.11 | ||
| 20-Day Raw Stochastic | 2.60% | 38.07% | 15.57% | ||
| 20-Day Relative Strength | 24.61% | 56.61% | 44.23% | ||
| Weighted Alpha | -71.78 | -71.18 | -88.13 | ||
| Today's Opinion | 100% Sell | 40% Sell | 88% Sell | ||
| Previous Opinion | 100% Sell | 56% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 80% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -15.65% since 07/15/24 | +48.60% since 07/15/24 | -12.47% since 07/15/24 | ||
| Low | 0.7700 on 07/22/24 | 1.0800 on 07/16/24 | 3.75 on 07/22/24 | ||
| High | 0.9436 on 07/19/24 | 2.4099 on 07/19/24 | 5.22 on 07/18/24 | ||
| 1-Month | |||||
| %Chg | -54.35% since 06/21/24 | +204.02% since 06/21/24 | -3.98% since 06/21/24 | ||
| Low | 0.7500 on 07/12/24 | 0.4835 on 07/01/24 | 3.41 on 06/26/24 | ||
| High | 1.7500 on 06/24/24 | 3.3900 on 07/10/24 | 6.30 on 07/10/24 | ||
| 3-Month | |||||
| %Chg | -67.26% since 04/22/24 | -51.82% since 04/22/24 | -32.85% since 04/22/24 | ||
| Low | 0.7500 on 07/12/24 | 0.4603 on 06/21/24 | 3.41 on 06/26/24 | ||
| High | 2.4900 on 05/06/24 | 3.3900 on 07/10/24 | 6.70 on 04/29/24 | ||
| 6-Month | |||||
| %Chg | -59.58% since 01/22/24 | -48.16% since 01/22/24 | -32.95% since 01/22/24 | ||
| Low | 0.7500 on 07/12/24 | 0.4603 on 06/21/24 | 3.41 on 06/26/24 | ||
| High | 3.5900 on 04/12/24 | 5.4800 on 03/11/24 | 25.00 on 02/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,553 | 3,584 | 3,264 | ||
| Shares Outstanding, K | 4,407 | 2,108 | 835 | ||
| Annual Sales | 5,850,000 | 0 | 0 | ||
| Annual Net Income | -7,910,000 | -15,190,000 | -98,300,000 | ||
| Last Quarter Sales | 3,330,985 | 0 | 0 | ||
| Last Quarter Net Income | -2,501,777 | -3,220,000 | -2,830,000 | ||
| 60-Month Beta | 1.14 | 1.16 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -2.75 on 05/13/24 | -4.53 on 05/15/24 | ||
| Latest Earnings Date | 09/04/24 | 08/12/24 | 08/19/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||